vitrogro ecm meets ce mark requirements , page-2

Thank you Steve and the management team as Tissue Therapies for all the hard work leading up to this milestone. It's been a long grind over six years since I first invested.

The risk of not getting formal approval now is zero as I see it.

I like the use of the term "initial product". I wonder what else TIS has in mind after VitroGro? So we have the fun now of waiting for news on marketing strategies, sales volumes and margins, for VitroGro to tap into more markets, and also to hear more about the next product.

Also very positive is that the initial approval covers burns and acute wounds in patients with compromised healing, as well as ulcers.